Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Neurofibromatoses × Nitrous Oxide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Solitary Pulmonary Nodule 1 Neurofibromatoses 1 Neoplasms 1 Multiple Pulmonary Nodules 1 Lung Neoplasms 1 Hydrocephalus 1 Headache 1 Epilepsy 1 Abdominal Neoplasms 1

Interventions

tipifarnib 1 nilotinib 1 mirdametinib 1 cabozantinib 1 binimetinib 1 Sunitinib 1 Sevoflurane 1 Propofol 1 Percutaneous Collagen Induction 1 Nitrous Oxide 1 Lidocaine 1 Imatinib Mesylate 1 Glycopyrrolate 1 Dexmedetomidine 1 Aminolevulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03513757 2020-02-21

Dexmedetomidine and Propofol for Pediatric MRI Sedation

Medical College of Wisconsin

Phase 4 Completed

40 enrolled 15 charts

Abdominal Neoplasms, Epilepsy, Headache, Hydrocephalus, Neoplasms, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon ⚡